FDA Inspection 1208499 — Vaughn, Silverberg, & Associates, LLP

Vaughn, Silverberg, & Associates, LLP — FEI 3009806344

The FDA completed an inspection of Vaughn, Silverberg, & Associates, LLP on June 21, 2023 in New Braunfels, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Braunfels, TX (United States)

Citations

IDCFRDescription
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence